The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Fu, Ying Kai ^a,c   Shen, Lie Hang ^a   Tseng, Yu Chin ^a   Liao, Mei Hsiu ^a,b  

^a INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; 2 KETANSERIN I 123; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; ALTANSERIN F 18; ALTROPANE; AMYLOID BETA PROTEIN; CITALOPRAM; DONEPEZIL; DOPAMINE TRANSPORTER; EPIDRPRIDE I 123; FDDNP F 18; FLORBETABEN; FLORBETAPIR F 18; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; FLUTEMETAMOL F 18; IODOBENZAMIDE I 123; LEVODOPA; METHYLBENPERIDOL F 18; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE I 123; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; PAROXETINE; PITTSBURGH COMPOUND B; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN; SERTRALINE; SETOPERONE F 18; SPIPERONE F 18; UNCLASSIFIED DRUG; VENLAFAXINE;

ALZHEIMER DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC SYSTEM; EARLY DIAGNOSIS; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MOLECULAR IMAGING; MOOD DISORDER; NEUROIMAGING; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; REVIEW; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; MENTAL DISEASE; METHODOLOGY;

ALZHEIMER DISEASE; HUMANS; MENTAL DISORDERS; MOLECULAR IMAGING; MOOD DISORDERS; PARKINSON DISEASE;

EID: 79959361265     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/439397     Document Type: Review

References (86)

1. Fumita M., Innis R. B., In vivo molecular imaging: ligand development and research applications Neuropsychopharmacology: The Fifth Generation of Progress 2000 411 425
2. Heiss W. D., Herholz K., Brain receptor imaging Journal of Nuclear Medicine 2006 47 2 302 312 (Pubitemid 46780896)
3. Pavese N., Kiferle L., Piccini P., Neuroprotection and imaging studies in Parkinson's disease Parkinsonism and Related Disorders 2010 15 4 S33 S37
4. Gelb D. J., Oliver E., Gilman S., Diagnostic criteria for Parkinson disease Archives of Neurology 1999 56 1 33 39 (Pubitemid 29046907)
5. Tolosa E., Wenning G., Poewe W., The diagnosis of Parkinson's disease Lancet Neurology 2006 5 1 75 86 (Pubitemid 41790698)
6. Hughes A. J., Daniel S. E., Blankson S., Lees A. J., A clinicopathologic study of 100 cases of Parkinson's disease Archives of Neurology 1993 50 2 140 148 (Pubitemid 23054795)
7. Rajput A. H., Rozdilsky B., Rajput A., Accuracy of clinical diagnosis in Parkinsonisma prospective study Canadian Journal of Neurological Sciences 1991 18 3 275 278
8. Sioka C., Fotopoulos A., Kyritsis A. P., Recent advances in PET imaging for evaluation of Parkinson's disease European Journal of Nuclear Medicine and Molecular Imaging 2010 37 1594 1603
9. Brooks D. J., Frey K. A., Marek K. L., Oakes D., Paty D., Prentice R., Shults C. W., Stoessl A. J., Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease Experimental Neurology 2003 184 1 S68 S79
10. Pavese N., Brooks D. J., Imaging neurodegeneration in Parkinson's disease Biochimica et Biophysica Acta 2009 1792 7 722 729
11. Ribeiro M. J., Vidailhet M., Loc'h C., Dupel C., Nguyen J. P., Ponchant M., Doll F., Peschanski M., Hantraye P., Cesaro P., Samson Y., Remy P., Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease Archives of Neurology 2002 59 4 580 586 (Pubitemid 34289961)
12. Meegalla S. K., Plssl K., Kung M. P., Chumpradit S., Stevenson D. A., Kushner S. A., McElgin W. T., Mozley P. D., Kung H. F., Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents Journal of Medicinal Chemistry 1997 40 1 9 17 (Pubitemid 27027260)
13. Mozley P. D., Schneider J. S., Acton P. D., Plssl K., Stern M. B., Siderowf A., Leopold N. A., Li P. Y., Alavi A., Kung H. F., Binding of [ 99mTc ]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers Journal of Nuclear Medicine 2000 41 4 584 589 (Pubitemid 30207731)
14. Huang W. S., Chiang Y. H., Lin J. C., Chou Y. H., Cheng C. Y., Liu R. S., Crossover study of 99mTc -TRODAT-1 SPECT and 18F -FDOPA PET in Parkinson's disease patients Journal of Nuclear Medicine 2003 44 7 999 1005
15. Weng Y. H., Yen T. C., Chen M. C., Kao P. F., Tzen K. Y., Chen R. S., Wey S. P., Ting G., Lu C. S., Sensitivity and specificity of 99mTc -TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects Journal of Nuclear Medicine 2004 45 3 393 401 (Pubitemid 47618611)
16. Nurmi E., Ruottinen H. M., Bergman J., Haaparanta M., Solin O., Sonninen P., Rinne J. O., Rate of progression in Parkinson's disease: a 6-[ 18F ]fluoro-L-dopa PET study Movement Disorders 2001 16 4 608 615 (Pubitemid 36040839)
17. Farde L., Pauli S., Hall H., Eriksson L., Halldin C., Hogberg T., Nilsson L., Sjogren I., Stone-Elander S., Stereoselective binding of 11C-raclopride in living human brain-A search for extrastriatal central D2-dopamine receptors by PET Psychopharmacology 1988 94 4 471 478 (Pubitemid 18087395)
18. Tzen K. Y., Lu C. S., Yen T. C., Wey S. P., Ting G., Differential diagnosis of Parkinson's disease and vascular parkinsonism by [ 99mTc ]-TRODAT-1 Journal of Nuclear Medicine 2001 42 3 408 413 (Pubitemid 32207389)
19. Koch W., Hamann C., Radau P. E., Tatsch K., Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? European Journal of Nuclear Medicine and Molecular Imaging 2007 34 8 1265 1273 (Pubitemid 47290664)
20. Plotkin M., Amthauer H., Klaffke S., Khn A., Ldemann L., Arnold G., Wernecke K. D., Kupsch A., Felix R., Venz S., Combined 123I -FP-CIT and I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients Journal of Neural Transmission 2005 112 5 677 692 (Pubitemid 40591200)
21. Pahwa R., Lyons K. E., Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines The American Journal of Managed Care 2010 16 S94 99
22. Weng Y. H., Chou Y. H. W., Wu W. S., Lin K. J., Chang H. C., Yen T. C., Chen R. S., Wey S. P., Lu C. S., PINK1 mutation in Taiwanese early-onset parkinsonismml: clinical, genetic, and dopamine transporter studies Journal of Neurology 2007 254 10 1347 1355
23. Yen T. C., Tzen K. Y., Chen M. C., Chou Y. H. W., Chen R. S., Chen C. J., Wey S. P., Ting G., Lu C. S., Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers Journal of Nuclear Medicine 2002 43 2 153 159 (Pubitemid 34151036)
24. Antonini A., Imaging for early differential diagnosis of parkinsonism The Lancet Neurology 2010 9 2 130 131
25. Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J. Q., Eidelberg D., Fahn S., Transplantation of embryonic dopamine neurons for severe Parkinson's disease New England Journal of Medicine 2001 344 10 710 719 (Pubitemid 32204988)
26. Ma Y., Tang C., Chaly T., Greene P., Breeze R., Fahn S., Freed C., Dhawan V., Eidelberg D., Dopamine cell implantation in Parkinson's disease: long-term clinical and 18F -FDOPA PET outcomes Journal of Nuclear Medicine 2010 51 1 7 15
27. Lang A. E., Gill S., Patel N. K., Lozano A., Nutt J. G., Penn R., Brooks D. J., Hotton G., Moro E., Heywood P., Brodsky M. A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V. G. F., Elias W. J., Laws E. R., Dhawan V., Stoessl A. J., Matcham J., Coffey R. J., Traub M., Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Annals of Neurology 2006 59 3 459 466 (Pubitemid 43358066)
28. Berry A. L., Foltynie T., Gene therapy: a viable therapeutic strategy for Parkinson's disease? Journal of Neurology 2010 258 179 188
29. Marks W. J. Jr., Ostrem J. L., Verhagen L., Starr P. A., Larson P. S., Bakay R. A., Taylor R., Cahn-Weiner D. A., Stoessl A. J., Olanow C. W., Bartus R. T., Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial The Lancet Neurology 2008 7 5 375 376
30. Kaplitt M. G., Feigin A., Tang C., Fitzsimons H. L., Mattis P., Lawlor P. A., Bland R. J., Young D., Strybing K., Eidelberg D., During M. J., Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial Lancet 2007 369 9579 2097 2105 (Pubitemid 46935946)
31. Eberling J. L., Jagust W. J., Christine C. W., Starr P., Larson P., Bankiewicz K. S., Aminoff M. J., Results from a phase I safety trial of hAADC gene therapy for Parkinson disease Neurology 2008 70 21 1980 1983
32. Leriche L., Bjrklund T., Breysse N., Besret L., Grgoire M. C., Carlsson T., Doll F., Mandel R. J., Dglon N., Hantraye P., Kirik D., Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy Journal of Neuroscience 2009 29 5 1544 1553
33. Muramatsu S. I., Fujimoto K. I., Kato S., Mizukami H., Asari S., Ikeguchi K., Kawakami T., Urabe M., Kume A., Sato T., Watanabe E., Ozawa K., Nakano I., A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease Molecular Therapy 2010 18 1731 1735
34. Blennow K., de Leon M. J., Zetterberg H., Alzheimers disease Lancet 2006 368 387 403
35. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer's disease Alzheimer's and Dementia 2007 3 3 186 191 (Pubitemid 46825511)
36. Kadir A., Nordberg A., Target-specific PET probes for neurodegenerative disorders related to dementia Journal of Nuclear Medicine 2010 51 9 1418 1430
37. Mattson M. P., Pathways towards and away from Alzheimer's disease Nature 2004 430 7000 631 639 (Pubitemid 39061671)
38. Jagust W., Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia Alzheimer's and Dementia 2006 2 1 36 42 (Pubitemid 43264482)
39. Silverman D. H. S., Small G. W., Phelps M. E., Clinical value of neuroimaging in the diagnosis of dementia. Sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer's disease Clinical Positron Imaging 1999 2 3 119 130
40. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Lngstrm B., Nordberg A., Two-year follow-up of amyloid deposition in patients with Alzheimer's disease Brain 2006 129 11 2856 2866 (Pubitemid 44684508)
41. Nordberg A., PET imaging of amyloid in Alzheimer's disease Lancet Neurology 2004 3 9 519 527 (Pubitemid 39485859)
42. Nordberg A., Amyloid imaging in Alzheimer's disease Neuropsychologia 2008 46 6 1636 1641
43. Nordberg A., Amyloid plaque imaging in vivo: current achievement and future prospects European Journal of Nuclear Medicine and Molecular Imaging 2008 35 1 S46 S50
44. Valotassiou V., Archimandritis S., Sifakis N., Papatriantafyllou J., Georgoulias P., Alzheimer's disease: SPECT and PET tracers for beta-amyloid imaging Current Alzheimer Research 2010 7 6 477 486
45. Shoghi-Jadid K., Small G. W., Agdeppa E. D., Kepe V., Ercoli L. M., Siddarth P., Read S., Satyamurthy N., Petric A., Huang S. C., Barrio J. R., Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with alzheimer disease American Journal of Geriatric Psychiatry 2002 10 1 24 35 (Pubitemid 34052900)
46. Mathis C. A., Bacskai B. J., Kajdasz S. T., McLellan M. E., Frosch M. P., Hyman B. T., Holt D. P., Wang Y., Huang G. F., Debnath M. L., Klunk W. E., A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain Bioorganic and Medicinal Chemistry Letters 2002 12 3 295 298 (Pubitemid 34113887)
47. Klunk W. E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D. P., Bergstrm M., Savitcheva I., Huang G. F., Estrada S., Ausn B., Debnath M. L., Barletta J., Price J. C., Sandell J., Lopresti B. J., Wall A., Koivisto P., Antoni G., Mathis C. A., Lngstrm B., Imaging Brain Amyloid in Alzheimer's Disease with Pittsburgh Compound-B Annals of Neurology 2004 55 3 306 319 (Pubitemid 38269583)
48. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., Kokmen E., Mild cognitive impairment: clinical characterization and outcome Archives of Neurology 1999 56 3 303 308 (Pubitemid 29120227)
49. Landau S. M., Harvey D., Madison C. M., The Alzheimer's Disease Neuroimaging Initiative. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging. In press
50. Forsberg A., Engler H., Almkvist O., Blomquist G., Hagman G., Wall A., Ringheim A., Lngstrm B., Nordberg A., PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiology of Aging 2008 29 10 1456 1465
51. Wong D. F., Rosenberg P. B., Zhou Y., Kumar A., Raymont V., Ravert H. T., Dannals R. F., Nandi A., Brasi J. R., Ye W., Hilton J., Lyketsos C., Kung H. F., Joshi A. D., Skovronsky D. M., Pontecorvo M. J., In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18) Journal of Nuclear Medicine 2010 51 6 913 920
52. Verhoeff N. P. L. G., Wilson A. A., Takeshita S., Trop L., Hussey D., Singh K., Kung H. F., Kung M. P., Houle S., In-vivo imaging of Alzheimer disease -amyloid with [ 11C ]SB-13 PET American Journal of Geriatric Psychiatry 2004 12 6 584 595 (Pubitemid 41031060)
53. Tolboom N., Van Der Flier W. M., Boverhoff J., Yaqub M., Wattjes M. P., Raijmakers P. G., Barkhof F., Scheltens P., Herholz K., Lammertsma A. A., Van Berckel B. N.M., Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images Journal of Neurology, Neurosurgery and Psychiatry 2010 81 8 882 884
54. Vandenberghe R., Van Laere K., Ivanoiu A., 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial Annals of Neurology 2010 68 319 329
55. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
56. Kadir A., Andreasen N., Almkvist O., Wall A., Forsberg A., Engler H., Hagman G., Lrkster M., Winblad B., Zetterberg H., Blennow K., Lngstrm B., Nordberg A., Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease Annals of Neurology 2008 63 5 621 631
57. Kuhl D. E., Minoshima S., Frey K. A., Foster N. L., Kilbourn M. R., Koeppe R. A., Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex Annals of Neurology 2000 48 3 391 395
58. Parsey R. V., Serotonin receptor imaging: clinically useful? Journal of Nuclear Medicine 2010 51 10 1495 1498
59. Sobczak S., Honig A., van Duinen M. A., Riedel W. J., Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies Bipolar Disorders 2002 4 6 347 356 (Pubitemid 36041464)
60. Neumeister A., Bain E., Nugent A. C., Carson R. E., Bonne O., Luckenbaugh D. A., Eckelman W., Herscovitch P., Charney D. S., Drevets W. C., Reduced serotonin type 1 receptor binding in panic disorder Journal of Neuroscience 2004 24 3 589 591 (Pubitemid 38166482)
61. Drevets W. C., Frank E., Price J. C., Kupfer D. J., Holt D., Greer P. J., Huang Y., Gautier C., Mathis C., PET imaging of serotonin 1A receptor binding in depression Biological Psychiatry 1999 46 10 1375 1387
62. Drevets W. C., Frank E., Price J. C., Kupfer D. J., Greer P. J., Mathis C., Serotonin type-1A receptor imaging in depression Nuclear Medicine and Biology 2000 27 5 499 507 (Pubitemid 30658154)
63. Blin J., Sette G., Fiorelli M., Bletry O., Elghozi J. L., Crouzel C., Baron J. C., A method for the in vivo investigation in the serotonergic 5-H T2 receptors in the human cerebral cortex using positron emission tomography and 18F -labeled setoperone Journal of Neurochemistry 1990 54 5 1744 1754
64. Blin J., Baron J. C., Dubois B., Crouzel C., Fiorelli M., Attar-Levy D., Pillon B., Fournier D., Vidailhet M., Agid Y., Loss of brain 5-H T2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [ 18F ]setoperone Brain 1993 116 3 497 510 (Pubitemid 23203635)
65. Ngan E. T. C., Yatham L. N., Ruth T. J., Liddle P. F., Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a pet study using [ 18F ]setoperone American Journal of Psychiatry 2000 157 6 1016 1018 (Pubitemid 30412359)
66. Wolf W. A., Kuhn D. M., Modulation of serotonin release: interactions between the serotonin transporter and autoreceptors Annals of the New York Academy of Sciences 1990 604 505 513
67. Suehiro M., Scheffel U., Ravert H. T., Dannals R. F., Wagner H. N., [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET Life Sciences 1993 53 11 883 892
68. Hesse S., Barthel H., Schwarz J., Sabri O., Mller U., Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders Neuroscience and Biobehavioral Reviews 2004 28 6 547 563 (Pubitemid 39446481)
69. Meyer J. H., Imaging the serotonin transporter during major depressive disorder and antidepressant treatment Journal of Psychiatry and Neuroscience 2007 32 2 86 102 (Pubitemid 46597955)
70. Lin K. J., Liu C. Y., Wey S. P., Hsiao I. T., Wu J., Fu Y. K., Yen T. C., Brain SPECT imaging and whole-body biodistribution with [ 123I ]ADAMa serotonin transporter radiotracer in healthy human subjects Nuclear Medicine and Biology 2006 33 2 193 202
71. Bhagwagar Z., Murthy N., Selvaraj S., Hinz R., Taylor M., Fancy S., Grasby P., Cowen P., 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [ 11C ]DASB American Journal of Psychiatry 2007 164 12 1858 1865 (Pubitemid 351739239)
72. Parsey R. V., Hastings R. S., Oquendo M. A., Huang Y. Y., Simpson N., Arcement J., Huang Y., Ogden R. T., Van Heertum R. L., Arango V., Mann J. J., Lower serotonin transporter binding potential in the human brain during major depressive episodes American Journal of Psychiatry 2006 163 1 52 58 (Pubitemid 43050103)
73. Meyer J. H., Wilson A. A., Ginovart N., Goulding V., Hussey D., Hood K., Houle S., Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [ 11C ]DASB PET imaging study American Journal of Psychiatry 2001 158 11 1843 1849 (Pubitemid 33054777)
74. Meyer J. H., Houle S., Sagrati S., Carella A., Hussey D. F., Ginovart N., Goulding V., Kennedy J., Wilson A. A., Brain serotonin transporter binding potential measured with [ 11C ]DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes Archives of General Psychiatry 2004 61 12 1271 1279 (Pubitemid 39602843)
75. Newberg A. B., Amsterdam J. D., Wintering N., Ploessl K., Swanson R. L., Shults J., Alavi A., 123 I -ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study Journal of Nuclear Medicine 2005 46 6 973 977 (Pubitemid 43733512)
76. Herold N., Uebelhack K., Franke L., Amthauer H., Luedemann L., Bruhn H., Felix R., Uebelhack R., Plotkin M., Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [ 123I ]-ADAM Journal of Neural Transmission 2006 113 5 659 670 (Pubitemid 43673605)
77. Sobczak S., Honig A., van Duinen M. A., Riedel W. J., Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies Bipolar Disorders 2002 4 6 347 356 (Pubitemid 36041464)
78. Murray G., Johnson S. L., The clinical significance of creativity in bipolar disorder Clinical Psychology Review 2010 30 721 732
79. Chou Y. H., Wang S. J., Lin C. L., Mao W. C., Lee S. M., Liao M. H., Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study Bipolar Disorders 2010 12 3 312 318
80. Chang T. T., Yeh T. L., Chiu N. T., Chen PO. S., Huang H. Y., Yang Y. K., Lee I. H., Lu RU. B., Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [ 99mTc ] TRODAT-1 Bipolar Disorders 2010 12 1 102 106
81. Yang Y. K., Yao W. J., Yeh T. L., Lee I. H., Chen K. C., Lu R. B., Association between serotonin transporter availability and hostility scores in healthy volunteersa single photon emission computed tomography study with [ 123I ] ADAM Psychiatry Research 2007 154 3 281 284 (Pubitemid 46428531)
82. Hiemke C., Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? European Archives of Psychiatry and Clinical Neuroscience 2008 258 1, supplement 21 27 (Pubitemid 351421448)
83. Sekine M., Arakawa R., Ito H., Okumura M., Sasaki T., Takahashi H., Takano H., Okubo Y., Halldin C., Suhara T., Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[ 18F ]FMeNER-D Psychopharmacology 2010 210 331 336
84. Ding Y. S., Singhal T., Planeta-Wilson B., Gallezot J. D., Nabulsi N., Labaree D., Ropchan J., Henry S., Williams W., Carson R. E., Neumeister A., Malison R. T., PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[ 11C ]O-methylreboxetine and HRRT Synapse 2010 64 1 30 38
85. rgyeln M., Szab Z., Kany B., Tancs A., Kovcs Z., Janka Z., Pvics L., Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc -TRODAT-1 SPECT study Journal of Affective Disorders 2005 89 1-3 115 123 (Pubitemid 41740839)
86. Farde L., Wiesel F. A., Halldin C., Sedvall G., Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs Archives of General Psychiatry 1988 45 1 71 76 (Pubitemid 18018572)